Sorafenib is an active ingredient in the original anticancer drug Nexavar. Included in the group of protein kinase inhibitors. Sorafenib inhibits the development of tumor cells. The drug was first released in Germany by the pharmaceutical company Bayer AG. The pills were expensive and out of reach for most patients with tumors.
Quality assurance is the top priority of ProvenExpert's terms of use and evaluation guidelines.
However, should you feel that a review is in violation of our guidelines, you can submit a request to have the review assessed by the ProvenExpert quality assurance team by using the following contact form.
Send email to reviewer
* Required fields
You have already posted this review on . Posting again might create duplication.
Continue?